Safety and Acceptability of SPL7013 Gel (VivaGel™) in Sexually Active Women

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2007
There is an urgent need for HIV prevention methods that women can initiate and control themselves. Topical microbicides, substances that kill microbes, represent one such method. The purpose of this study is to assess the safety and to evaluate the acceptability of 3% w/w SPL7013 gel, a topical microbicide, when administered intravaginally for 14 consecutive days in healthy, sexually active HIV uninfected women.
Epistemonikos ID: 3aabab110857635ac5bfe09e55c13299ae096e83
First added on: Dec 01, 2021